Students explore selected pharmacological therapies used to treat anxiety, depression, and various psychotic disorders. They examine pharmacological treatments for diseases related to child and adolescent development and geriatric populations. They apply critical thinking skills to examine how genetic, developmental, and environmental factors influence, at the molecular level, cerebrum structure and function. Students investigate topics including neuropsychopharmacology, pharmacokinetics, pharmacodynamics, placebos, nocebos, antipsychotic drugs, antidepressant drugs, and sedative-hypnotic drugs. Prerequisite: PSYC 1110 (min. grade D) and PSYC 1210 (min. grade D) and completion of 45 credits and one of the following: PSYC 2040 or BIOL 1050 or BIOL 1110 or permission of the instructor
Students explore selected pharmacological therapies used to treat anxiety, depression, and various psychotic disorders. They examine pharmacological treatments for diseases related to child and adolescent development and geriatric populations. They apply critical thinking skills to examine how genetic, developmental, and environmental factors influence, at the molecular level, cerebrum structure and function. Students investigate topics including neuropsychopharmacology, pharmacokinetics, pharmacodynamics, placebos, nocebos, antipsychotic drugs, antidepressant drugs, and sedative-hypnotic drugs. Prerequisite: PSYC 1110 (min. grade D) and PSYC 1210 (min. grade D) and completion of 45 credits and one of the following: PSYC 2040 or BIOL 1050 or BIOL 1110 or permission of the instructor
